Author:
Jackson David B.,Sood Anil K.
Publisher
Springer Science and Business Media LLC
Reference64 articles.
1. La Rosée, P. & Deininger, M. W. Resistance to imatinib: mutations and beyond. Semin. Hematol. 47, 335–343 (2010).
2. Gerber, D. E. & Minna, J. D. ALK inhibition for non-small cell lung cancer: from discovery to therapy in record time. Cancer Cell 14, 548–551 (2010).
3. Smalley, K. S. PLX-4032, a small-molecule B-Raf inhibitor for the potential treatment of malignant melanoma. Curr. Opin. Investig. Drugs 11, 699–706 (2010).
4. Jackson, D. B. Molecular perspectives on the non-responder phenomenon. Drug Discov. Today 14, 373–379 (2009).
5. Hayes, D. F. Bevacizumab treatment for solid tumors: boon or bust? JAMA 305, 506–508 (2011).
Cited by
21 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献